Article thumbnail

Effectiveness of erlotinib treatment in advanced KRAS mutation-negative lung adenocarcinoma patients: Results of a multicenter observational cohort study (MOTIVATE)

By Veronika Sarosi, Gyorgy Losonczy, Eva Francovszky, Edina Tolnay, Szilvia Torok, Gabriella Galffy, Balazs Hegedus, Balazs Dome and Gyula Ostoros
Publisher: Elsevier BV
Year: 2014
DOI identifier: 10.1016/j.lungcan.2014.07.011
OAI identifier:
Provided by: MUCC (Crossref)
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • (external link)

  • To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

    Suggested articles